Insights

Hematology Focus Oncopeptides specializes in therapies for difficult-to-treat hematological diseases, presenting a clear opportunity to align sales outreach with hematology-focused care providers, hospital systems, and research institutions seeking innovative cancer treatments.

U.S. Presence With a U.S. headquarters in Waltham and additional activity in Los Altos, there is a viable entry point for business development efforts targeting biotech clusters and healthcare networks in Massachusetts and California.

Growth Readiness Revenue in the low to mid eight-figure range alongside a lean employee base suggests opportunities for strategic partnerships, pilot programs, and value-based collaboration with larger pharma players or CROs seeking niche hematology assets.

Tech Enablement The existing tech stack (Azure, CMS, analytics, and performance optimization tools) indicates a modern digital footprint that can be leveraged for data-driven collaborations, digital ecosystems, and patient engagement initiatives.

Strategic Partnerships Positioning alongside major industry peers in the profiling of Oncopeptides enables targeted outreach to potential investors, licensees, and co-development partners seeking synergistic opportunities in oncology and hematology.

Oncopeptides, Inc. (U.S.) Tech Stack

Oncopeptides, Inc. (U.S.) uses 8 technology products and services including Open Graph, Optimizely Content Management, MySQL, and more. Explore Oncopeptides, Inc. (U.S.)'s tech stack below.

  • Open Graph
    Content Management System
  • Optimizely Content Management
    Content Management System
  • MySQL
    Database
  • Google Maps
    Maps
  • PWA
    Miscellaneous
  • Kinsta
    Platform As A Service
  • Microsoft Azure
    Platform As A Service
  • HSTS
    Security

Media & News

Oncopeptides, Inc. (U.S.)'s Email Address Formats

Oncopeptides, Inc. (U.S.) uses at least 2 format(s):
Oncopeptides, Inc. (U.S.) Email FormatsExamplePercentage
First.Last@oncopeptides.comJohn.Doe@oncopeptides.com
91%
FirstLast@oncopeptides.comJohnDoe@oncopeptides.com
4%
First.Middle.Last@oncopeptides.comJohn.Michael.Doe@oncopeptides.com
3%
LastF@oncopeptides.comDoeJ@oncopeptides.com
2%
First-Last@oncopeptides-us.comJohn-Doe@oncopeptides-us.com
67%
LastF@oncopeptides-us.comDoeJ@oncopeptides-us.com
33%

Frequently Asked Questions

Where is Oncopeptides, Inc. (U.S.)'s headquarters located?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s main headquarters is located at 200 Fifth Avenue Suite #1030 Waltham, MA 02451 US. The company has employees across 2 continents, including North AmericaEurope.

What is Oncopeptides, Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s official website is oncopeptides-us.com and has social profiles on LinkedIn.

What is Oncopeptides, Inc. (U.S.)'s NAICS code?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Oncopeptides, Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of November 2021, Oncopeptides, Inc. (U.S.) has approximately 201 employees across 2 continents, including North AmericaEurope. Key team members include Head Of Research: F. L.Head Of Us Human Resources: M. F.Executive Director, Medical Affairs: E. M.. Explore Oncopeptides, Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Oncopeptides, Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) operates in the Pharmaceutical Manufacturing industry.

What technology does Oncopeptides, Inc. (U.S.) use?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s tech stack includes Open GraphOptimizely Content ManagementMySQLGoogle MapsPWAKinstaMicrosoft AzureHSTS.

What is Oncopeptides, Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s email format typically follows the pattern of First.Last@oncopeptides.com. Find more Oncopeptides, Inc. (U.S.) email formats with LeadIQ.

When was Oncopeptides, Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) was founded in 2000.
Oncopeptides, Inc. (U.S.) logo

Oncopeptides, Inc. (U.S.)

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

Oncopeptides, Inc. operates within the pharmaceutical manufacturing sector, focusing on developing therapies for difficult-to-treat hematological diseases. The company aims to provide treatment options driven by scientific research and innovation, with a mission that centers on offering new possibilities to patients, caregivers, and healthcare providers dealing with cancer. Its U.S. presence is headquartered in Waltham, Massachusetts, with additional footprint in California, and its global headquarters are in Stockholm, Sweden, reflecting a bi-national orientation and a broader development platform.

Positioned in the specialty biopharma space, Oncopeptides concentrates on addressing unmet clinical needs in hematology. The organization serves a medical and professional audience that seeks advanced treatment options for challenging blood cancers, operating from multiple U.S. locations to support its activities in a major biotechnology corridor. The information indicates a formal corporate footprint in the Boston-area region to facilitate its U.S. operations and research collaborations.

Section iconCompany Overview

Headquarters
200 Fifth Avenue Suite #1030 Waltham, MA 02451 US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2000
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.